ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
MenQuadfi, solution injectable - 
68221001 Sanofi-Aventis (Suisse) SA
MenQuadfi, solution injectable05.10.2022
  05.10.2022
Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated (J07AH08) 
WHO-DDD04.10.2027
08.08. 
08.08. 
B  
Yes 
IP 
41.15Yes
    
10 %61.15
  
7680682210015Impfstoffe
  
Composition
polysaccharida neisseriae meningitidis A 10 µg et polysaccharida neisseriae meningitidis C 10 µg et polysaccharida neisseriae meningitidis Y 10 µg et polysaccharida neisseriae meningitidis W-135 10 µg conjugatum cum toxoidum tetani 55 µg, natrii chloridum, natrii acetas ut natrii acetas trihydricus et acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.67 mg.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Conjugatum cum Toxoidum Tetani55µg / 0.5ml
Polysaccharida Neisseriae Meningitidis A10µg / 0.5ml
Polysaccharida Neisseriae Meningitidis C10µg / 0.5ml
Polysaccharida Neisseriae Meningitidis Y10µg / 0.5ml
BAG: Active AgentDose
Polysaccharida Neisseriae Meningitidis A10 mcg
Polysaccharida Neisseriae Meningitidis C10 mcg
Polysaccharida Neisseriae Meningitidis W-13510 mcg
Polysaccharida Neisseriae Meningitidis Y10 mcg
Vaccinum Meningitidis Polysaccharid. Tetravalens A, C, W135, y Conjugatum T 
 
Inactive agentsDose
Acidum Aceticum Glaciale 
Sodium Acetate 
Sodium Chloride 
Polysaccharida Neisseriae Meningitidis W-13510µg / 0.5ml
 
Source
Data was imported : 04.11.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home